User:Mark Macbeth/SandboxGiavanna
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | = | + | =SARS CoV-2 Protein Inhibitors (AHB2 and LCB1/LCB3)= |
| - | <StructureSection load=' | + | <StructureSection load='AHB2' size='340' side='right' caption='AHB2 Inhibitor'> |
| - | + | ||
| - | + | ||
| - | == | + | ==Introduction== |
| - | == | + | d) All content that you add will come next with appropriate subheaders for different sections |
| - | + | of your page (i.e ==Function== and ==Mechanism== on your generic page), with further | |
| - | == | + | subheadings like ===Active Site=== or ===Extracellular Domain=== (note the 3 ‘=’ signs) |
| - | + | e) </StructureSection> (This code ends the main content that you will have added) | |
| - | == | + | f) ==References== (A heading section for the articles you reference) |
| - | + | g) <references/> (code to list your actual full references here) | |
| - | + | h) ==Student Contributors== (a section for recognition of your team) | |
| - | + | *Name of Student | |
| - | </StructureSection> | + | Week 8 – Page 4 of 9 |
| - | == References == | + | *Name of Student |
| - | <references/> | + | *Name of Student |
Revision as of 18:50, 18 March 2025
SARS CoV-2 Protein Inhibitors (AHB2 and LCB1/LCB3)
| |||||||||||
f) ==References== (A heading section for the articles you reference) g) (code to list your actual full references here) h) ==Student Contributors== (a section for recognition of your team)
- Name of Student
Week 8 – Page 4 of 9
- Name of Student
- Name of Student
